Cargando…
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study †
Background: Many factors are believed to be positively associated with the incidence of relapses in people with multiple sclerosis (MS), including infections. However, their role is still controversial. We aimed to investigate whether symptomatic infections in people with MS increase the risk of rel...
Autores principales: | Miele, Giuseppina, Cepparulo, Simone, Abbadessa, Gianmarco, Lavorgna, Luigi, Sparaco, Maddalena, Simeon, Vittorio, Guizzaro, Lorenzo, Bonavita, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918238/ https://www.ncbi.nlm.nih.gov/pubmed/36769670 http://dx.doi.org/10.3390/jcm12031023 |
Ejemplares similares
-
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022) -
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021) -
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series
por: Abbadessa, Gianmarco, et al.
Publicado: (2022) -
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021) -
Viral pericarditis following ocrelizumab in a multiple sclerosis patient
por: Miele, Giuseppina, et al.
Publicado: (2023)